136
Views
126
CrossRef citations to date
0
Altmetric
Review

Current challenges in the development of vaccines for pneumonic plague

Pages 209-221 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Qingwen Zhang, Qiong Wang, Guang Tian, Zhizhen Qi, Xuecan Zhang, Xiaohong Wu, Yefeng Qiu, Yujing Bi, Xiaoyan Yang, Youquan Xin, Jian He, Jiyuan Zhou, Lin Zeng, Ruifu Yang & Xiaoyi Wang. (2014) Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques. Human Vaccines & Immunotherapeutics 10:2, pages 368-377.
Read now
Petra CF Oyston & E Diane Williamson. (2013) Prophylaxis and therapy of plague. Expert Review of Anti-infective Therapy 11:8, pages 817-829.
Read now
Xiaoyi Wang, Xuecan Zhang, Dongsheng Zhou & Ruifu Yang. (2013) Live-attenuated Yersinia pestis vaccines. Expert Review of Vaccines 12:6, pages 677-686.
Read now
Valentina A Feodorova & Vladimir L Motin. (2012) Plague vaccines: current developments and future perspectives. Emerging Microbes & Infections 1:1, pages 1-5.
Read now
Jason A Rosenzweig & Ashok K Chopra. (2012) The future of plague vaccines: hopes raised by a surrogate, live-attenuated recombinant vaccine candidate. Expert Review of Vaccines 11:6, pages 659-661.
Read now
Valentina A Feodorova & Michael J Corbel. (2009) Prospects for new plague vaccines. Expert Review of Vaccines 8:12, pages 1721-1738.
Read now

Articles from other publishers (120)

Amit K. Singh, Saugata Majumder, Xiuran Wang, Renjie Song & Wei Sun. (2023) Lung Resident Memory T Cells Activated by Oral Vaccination Afford Comprehensive Protection against Pneumonic Yersinia pestis Infection . The Journal of Immunology 210:3, pages 259-270.
Crossref
Ruifu Yang, Steve Atkinson, Ziqi Chen, Yujun Cui, Zongmin Du, Yanping Han, Florent Sebbane, Philip Slavin, Yajun Song, Yanfeng Yan, Yarong Wu, Lei Xu, Chutian Zhang, Yun Zhang, B. Joseph Hinnebusch, Nils Chr. Stenseth & Vladimir L. Motin. (2023) Yersinia pestis and Plague: Some Knowns and Unknowns. Zoonoses 3:1.
Crossref
Wei Zhang, Xiaolin Song, Lina Zhai, Jianshu Guo, Xinying Zheng, Lili Zhang, Meng Lv, Lingfei Hu, Dongsheng Zhou, Xiaolu Xiong & Wenhui Yang. (2022) Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation. Frontiers in Immunology 13.
Crossref
Raysa Rosario-Acevedo, Sergei S. Biryukov, Joel A. Bozue & Christopher K. Cote. (2021) Plague Prevention and Therapy: Perspectives on Current and Future Strategies. Biomedicines 9:10, pages 1421.
Crossref
Jason A. Rosenzweig, Emily K. Hendrix & Ashok K. Chopra. (2021) Plague vaccines: new developments in an ongoing search. Applied Microbiology and Biotechnology 105:12, pages 4931-4941.
Crossref
Christina D'Arco, Alison A. McCormick & Paul M. Arnaboldi. (2021) Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection. Vaccine 39:9, pages 1435-1444.
Crossref
Christopher K. Cote, Sergei S. Biryukov, Christopher P. Klimko, Jennifer L. Shoe, Melissa Hunter, Raysa Rosario-Acevedo, David P. Fetterer, Krishna L. Moody, Joshua R. Meyer, Nathaniel O. Rill, Jennifer L. Dankmeyer, Patricia L. Worsham, Joel A. Bozue & Susan L. Welkos. (2021) Protection Elicited by Attenuated Live Yersinia pestis Vaccine Strains against Lethal Infection with Virulent Y. pestis. Vaccines 9:2, pages 161.
Crossref
Paul B. Kilgore, Jian Sha, Jourdan A. Andersson, Vladimir L. Motin & Ashok K. Chopra. (2021) A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform. npj Vaccines 6:1.
Crossref
Junxia Feng, Yingying Deng, Mengjiao Fu, Xueyuan Hu, Wenbo Luo, Zhiyu Lu, Lupeng Dai, Huiying Yang, Xiaodong Zhao, Zongmin Du, Bohai Wen, Lingxiao Jiang, Dongsheng Zhou, Jun Jiao & Xiaolu Xiong. (2020) Construction of a Live-Attenuated Vaccine Strain of Yersinia pestis EV76-B-SHUΔpla and Evaluation of Its Protection Efficacy in a Mouse Model by Aerosolized Intratracheal Inoculation. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Ankit Gupta, Bineet Narayan, Subodh Kumar & Shailendra Kumar Verma. (2020) Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis. Frontiers in Immunology 11.
Crossref
Danielle A Wagner, Sean M Kelly, Andrew C Petersen, Nathan Peroutka-Bigus, Ross J Darling, Bryan H Bellaire, Michael J Wannemuehler & Balaji Narasimhan. (2019) Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague. Acta Biomaterialia 100, pages 326-337.
Crossref
William Bowen, Lalit Batra, Amanda R. Pulsifer, Esma S. Yolcu, Matthew B. Lawrenz & Haval Shirwan. (2019) Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague. Vaccine 37:38, pages 5708-5716.
Crossref
Catherine Daniel, Amélie Dewitte, Sabine Poiret, Michaël Marceau, Michel Simonet, Laure Marceau, Guillaume Descombes, Denise Boutillier, Nadia Bennaceur, Sébastien Bontemps-Gallo, Nadine Lemaître & Florent Sebbane. (2019) Polymorphism in the Yersinia LcrV Antigen Enables Immune Escape From the Protection Conferred by an LcrV-Secreting Lactococcus Lactis in a Pseudotuberculosis Mouse Model. Frontiers in Immunology 10.
Crossref
Seyed Mohammad Gheibi Hayat & Majid Darroudi. (2019) Nanovaccine: A novel approach in immunization. Journal of Cellular Physiology 234:8, pages 12530-12536.
Crossref
Christian Demeure, Olivier Dussurget, Guillem Mas Fiol, Anne-Sophie Le Guern, Cyril Savin & Javier Pizarro-Cerdá. (2019) Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination and diagnostics. Microbes and Infection 21:5-6, pages 202-212.
Crossref
Stephen T. Smiley, Frank M. Szaba, Lawrence W. Kummer, Debra K. Duso & Jr-Shiuan Lin. (2019) Yersinia pestis Pla Protein Thwarts T Cell Defense against Plague . Infection and Immunity 87:5.
Crossref
Christian E. Demeure, Olivier Dussurget, Guillem Mas Fiol, Anne-Sophie Le Guern, Cyril Savin & Javier Pizarro-Cerdá. (2019) Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics. Genes & Immunity 20:5, pages 357-370.
Crossref
Wei Sun & Amit K. Singh. (2019) Plague vaccine: recent progress and prospects. npj Vaccines 4:1.
Crossref
Shailendra K. Verma, Ankit Gupta, Lalit Batra & Urmil Tuteja. (2019) Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection. Vaccine 37:1, pages 19-24.
Crossref
Christian E. Demeure, Anne Derbise, Chloé Guillas, Christiane Gerke, Simon Cauchemez, Elisabeth Carniel & Javier Pizarro-Cerdá. (2019) Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine. Vaccine 37:1, pages 123-129.
Crossref
Pan Tao, Marthandan Mahalingam, Jingen Zhu, Mahtab Moayeri, Jian Sha, William S. Lawrence, Stephen H. Leppla, Ashok K. Chopra & Venigalla B. Rao. (2018) A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague. mBio 9:5.
Crossref
Yinon Levy, Yaron Vagima, Avital Tidhar, Moshe Aftalion, David Gur, Uri Nili, Theodore Chitlaru, Ayelet Zauberman & Emanuelle Mamroud. (2018) Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague. npj Vaccines 3:1.
Crossref
E. D’Ortenzio, N. Lemaître, C. Brouat, P. Loubet, F. Sebbane, M. Rajerison, L. Baril & Y. Yazdanpanah. (2018) Plague: Bridging gaps towards better disease control. Médecine et Maladies Infectieuses 48:5, pages 307-317.
Crossref
Valentina A. Feodorova, Anna M. Lyapina, Maria A. Khizhnyakova, Sergey S. Zaitsev, Lidiya V. Sayapina, Tatiana E. Arseneva, Alexey L. Trukhachev, Svetlana A. Lebedeva, Maxim V. Telepnev, Onega V. Ulianova, Elena P. Lyapina, Sergey S. Ulyanov & Vladimir L. Motin. (2018) Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine. PLOS Neglected Tropical Diseases 12:6, pages e0006511.
Crossref
Yujing Bi & Xiaoyi Wang. 2018. Yersinia Pestis Protocols. Yersinia Pestis Protocols 231 236 .
Sharon E. Frey, Kathleen Lottenbach, Irene Graham, Edwin Anderson, Kanwaldeep Bajwa, Ryan C. May, Steven B. Mizel, Aaron Graff & Robert B. Belshe. (2017) A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066). Vaccine 35:48, pages 6759-6765.
Crossref
Jourdan A. Andersson, Jian Sha, Tatiana E. Erova, Eric C. Fitts, Duraisamy Ponnusamy, Elena V. Kozlova, Michelle L. Kirtley & Ashok K. Chopra. (2017) Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Anat Zvi, Shahar Rotem, Ayelet Zauberman, Uri Elia, Moshe Aftalion, Erez Bar-Haim, Emanuelle Mamroud & Ofer Cohen. (2017) Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague. Vaccine 35:44, pages 5995-6006.
Crossref
Pan Tao, Marthandan Mahalingam, Jingen Zhu, Mahtab Moayeri, Michelle L. Kirtley, Eric C. Fitts, Jourdan A. Andersson, William S. Lawrence, Stephen H. Leppla, Ashok K. Chopra & Venigalla B. Rao. (2017) A Bivalent Anthrax–Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis. Frontiers in Immunology 8.
Crossref
Christian E. Demeure, Anne Derbise & Elisabeth Carniel. (2017) Oral vaccination against plague using Yersinia pseudotuberculosis. Chemico-Biological Interactions 267, pages 89-95.
Crossref
Norberto González-Juarbe, Haiqian Shen, Molly A. Bergman, Carlos J. Orihuela & Peter H. Dube. (2017) YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection. PLOS ONE 12:2, pages e0172314.
Crossref
Paul M. Arnaboldi, Mariya Sambir, Christina D’Arco, Lauren A. Peters, Jos F.M.L. Seegers, Lloyd Mayer, Alison A. McCormick & Raymond J. Dattwyler. (2016) Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Vaccine 34:47, pages 5768-5776.
Crossref
Bethany L Tiner, Jian Sha, Yingzi Cong, Michelle L Kirtley, Jourdan A Andersson & Ashok K Chopra. (2016) Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague. npj Vaccines 1:1.
Crossref
Han Wang, Rui Yu, Ting Fang, Ting Yu, Xiangyang Chi, Xiaopeng Zhang, Shuling Liu, Ling Fu, Changming Yu & Wei Chen. (2016) Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library. Toxins 8:9, pages 266.
Crossref
Shailendra K. Verma, Lalit Batra & Urmil Tuteja. (2016) A Recombinant Trivalent Fusion Protein F1–LcrV–HSP70(II) Augments Humoral and Cellular Immune Responses and Imparts Full Protection against Yersinia pestis. Frontiers in Microbiology 7.
Crossref
Jian Sha, Michelle L. Kirtley, Curtis Klages, Tatiana E. Erova, Maxim Telepnev, Duraisamy Ponnusamy, Eric C. Fitts, Wallace B. Baze, Satheesh K. Sivasubramani, William S. Lawrence, Igor Patrikeev, Jennifer E. Peel, Jourdan A. Andersson, Elena V. Kozlova, Bethany L. Tiner, Johnny W. Peterson, David McWilliams, Snehal Patel, Eric Rothe, Vladimir L. Motin & Ashok K. Chopra. (2016) A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates. Clinical and Vaccine Immunology 23:7, pages 586-600.
Crossref
Shilpa Sanapala, Hannah Rahav, Hetal Patel, Wei Sun & Roy Curtiss. (2016) Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague. Vaccine 34:21, pages 2410-2416.
Crossref
Zongmin Du & Xiaoyi Wang. 2016. Yersinia pestis: Retrospective and Perspective. Yersinia pestis: Retrospective and Perspective 193 222 .
Xiangna Zhao & Mikael Skurnik. 2016. Yersinia pestis: Retrospective and Perspective. Yersinia pestis: Retrospective and Perspective 361 375 .
Wei Sun. 2016. Yersinia pestis: Retrospective and Perspective. Yersinia pestis: Retrospective and Perspective 313 360 .
Pan Tao, Marthandan Mahalingam & Venigalla B. Rao. 2016. Vaccine Design. Vaccine Design 499 518 .
Valentina A. Feodorova, Lidiya V. Sayapina & Vladimir L. Motin. 2016. Vaccine Design. Vaccine Design 487 498 .
Amit K. Singh, Joseph J. Kingston, Shishir K. Gupta & Harsh V. Batra. (2015) Recombinant Bivalent Fusion Protein rVE Induces CD4+ and CD8+ T-Cell Mediated Memory Immune Response for Protection Against Yersinia enterocolitica Infection. Frontiers in Microbiology 6.
Crossref
Bethany L. Tiner, Jian Sha, Duraisamy Ponnusamy, Wallace B. Baze, Eric C. Fitts, Vsevolod L. Popov, Christina J. van Lier, Tatiana E. Erova & Ashok K. Chopra. (2015) Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague. Clinical and Vaccine Immunology 22:12, pages 1255-1268.
Crossref
Anne Derbise, Yuri Hanada, Manal Khalifé, Elisabeth Carniel & Christian E. Demeure. (2015) Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. PLOS Neglected Tropical Diseases 9:10, pages e0004162.
Crossref
Christina J. van Lier, Bethany L. Tiner, Sadhana Chauhan, Vladimir L. Motin, Eric C. Fitts, Matthew B. Huante, Janice J. Endsley, Duraisamy Ponnusamy, Jian Sha & Ashok K. Chopra. (2015) Further characterization of a highly attenuated Yersinia pestis CO92 mutant deleted for the genes encoding Braun lipoprotein and plasminogen activator protease in murine alveolar and primary human macrophages. Microbial Pathogenesis 80, pages 27-38.
Crossref
Wei Sun, Shilpa Sanapala, Jeremy C. Henderson, Shandiin Sam, Joseph Olinzock, M. Stephen Trent & Roy CurtissIIIIII. (2014) LcrV Delivered via Type III Secretion System of Live Attenuated Yersinia pseudotuberculosis Enhances Immunogenicity against Pneumonic Plague. Infection and Immunity 82:10, pages 4390-4404.
Crossref
Gunes Dinc, Jarrod M. Pennington, Esma S. Yolcu, Matthew B. Lawrenz & Haval Shirwan. (2014) Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant. Vaccine 32:39, pages 5035-5040.
Crossref
Yujun Cui, Xianwei Yang, Xiao Xiao, Andrey P. Anisimov, Dongfang Li, Yanfeng Yan, Dongsheng Zhou, Minoarisoa Rajerison, Elisabeth Carniel, Mark Achtman, Ruifu Yang & Yajun Song. (2014) Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries. Infection, Genetics and Evolution 26, pages 172-179.
Crossref
Christina J. van Lier, Jian Sha, Michelle L. Kirtley, Anthony Cao, Bethany L. Tiner, Tatiana E. Erova, Yingzi Cong, Elena V. Kozlova, Vsevolod L. Popov, Wallace B. Baze & Ashok K. Chopra. (2014) Deletion of Braun Lipoprotein and Plasminogen-Activating Protease-Encoding Genes Attenuates Yersinia pestis in Mouse Models of Bubonic and Pneumonic Plague. Infection and Immunity 82:6, pages 2485-2503.
Crossref
Frank M. Szaba, Lawrence W. Kummer, Debra K. Duso, Ekaterina P. Koroleva, Alexei V. Tumanov, Andrea M. Cooper, James B. Bliska, Stephen T. Smiley & Jr-Shiuan Lin. (2014) TNFα and IFNγ but Not Perforin Are Critical for CD8 T Cell-Mediated Protection against Pulmonary Yersinia pestis Infection. PLoS Pathogens 10:5, pages e1004142.
Crossref
Michael L. Fisher, Wei Sun & Roy CurtissIIIIII. (2014) The route less taken: pulmonary models of enteric Gram-negative infection. Pathogens and Disease 70:2, pages 99-109.
Crossref
Jessica Z. Kubicek-Sutherland, Douglas M. Heithoff, Selvi C. Ersoy, William R. Shimp & Michael J. Mahan. (2014) Immunization with a DNA adenine methylase over-producing Yersinia pseudotuberculosis vaccine confers robust cross-protection against heterologous pathogenic serotypes. Vaccine 32:13, pages 1451-1459.
Crossref
Maria Gomes-Solecki. 2014. Molecular Vaccines. Molecular Vaccines 767 779 .
Ayelet Zauberman, Yehuda Flashner, Yinon Levy, Yaron Vagima, Avital Tidhar, Ofer Cohen, Erez Bar-Haim, David Gur, Moshe Aftalion, Gideon Halperin, Avigdor Shafferman & Emanuelle Mamroud. (2013) YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia. PLoS ONE 8:12, pages e83560.
Crossref
Zejun Zhou, Huanying Pang, Yu Ding, Jia Cai, Yucong Huang, Jichang Jian & Zaohe Wu. (2013) VscO, a putative T3SS chaperone escort of Vibrio alginolyticus, contributes to virulence in fish and is a target for vaccine development. Fish & Shellfish Immunology 35:5, pages 1523-1531.
Crossref
Thomas Butler. (2013) Plague Gives Surprises in the First Decade of the 21st Century in the United States and Worldwide. The American Journal of Tropical Medicine and Hygiene 89:4, pages 788-793.
Crossref
Joseph D. Busch, Roger Van Andel, Nathan E. Stone, Kacy R. Cobble, Roxanne Nottingham, Judy Lee, Michael VerSteeg, Jeff Corcoran, Jennifer Cordova, William Van Pelt, Megan M. Shuey, Jeffrey T. Foster, James M. Schupp, Stephen Beckstrom-Sternberg, James Beckstrom-Sternberg, Paul Keim, Susan Smith, Julia Rodriguez-Ramos, Judy L. Williamson, Tonie E. Rocke & David M. Wagner. (2013) THE INNATE IMMUNE RESPONSE MAY BE IMPORTANT FOR SURVIVING PLAGUE IN WILD GUNNISON'S PRAIRIE DOGS. Journal of Wildlife Diseases 49:4, pages 920-931.
Crossref
Pan Tao, Marthandan Mahalingam, Michelle L. Kirtley, Christina J. van Lier, Jian Sha, Linsey A. Yeager, Ashok K. Chopra & Venigalla B. Rao. (2013) Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague Vaccines. PLoS Pathogens 9:7, pages e1003495.
Crossref
Anthony J. Hickey, Jr-Shiuan Lin, Lawrence W. Kummer, Frank M. Szaba, Debra K. Duso, Michael Tighe, Michelle A. Parent & Stephen T. Smiley. (2013) Intranasal Prophylaxis with CpG Oligodeoxynucleotide Can Protect against Yersinia pestis Infection. Infection and Immunity 81:6, pages 2123-2132.
Crossref
Deyan Luo, Jr-Shiuan Lin, Michelle A. Parent, Isis Mullarky-Kanevsky, Frank M. Szaba, Lawrence W. Kummer, Debra K. Duso, Michael Tighe, Jim Hill, Andras Gruber, Nigel Mackman, David Gailani & Stephen T. Smiley. (2013) Fibrin Facilitates Both Innate and T Cell–Mediated Defense against Yersinia pestis . The Journal of Immunology 190:8, pages 4149-4161.
Crossref
Pan Tao, Marthandan Mahalingam, Bernard S. Marasa, Zhihong Zhang, Ashok K. Chopra & Venigalla B. Rao. (2013) In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine. Proceedings of the National Academy of Sciences 110:15, pages 5846-5851.
Crossref
Gabriela Mellado-Sanchez, Karina Ramirez, Cinthia B. Drachenberg, Jovita Diaz-McNair, Ana L. Rodriguez, James E. Galen, James P. Nataro & Marcela F. Pasetti. (2013) Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain. Comparative Immunology, Microbiology and Infectious Diseases 36:2, pages 113-128.
Crossref
Tatiana E. Erova, Jason A. Rosenzweig, Jian Sha, Giovanni Suarez, Johanna C. Sierra, Michelle L. Kirtley, Christina J. van Lier, Maxim V. Telepnev, Vladimir L. Motin & Ashok K. Chopra. (2013) Evaluation of Protective Potential of Yersinia pestis Outer Membrane Protein Antigens as Possible Candidates for a New-Generation Recombinant Plague Vaccine. Clinical and Vaccine Immunology 20:2, pages 227-238.
Crossref
Mark T. Albrecht, Brian D. Livingston, John T. Pesce, Matt G. Bell, Drew Hannaman & Andrea M. Keane-Myers. (2012) Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague. Vaccine 30:32, pages 4872-4883.
Crossref
Anne Derbise, Alba Cerdà Marín, Patrick Ave, Thierry Blisnick, Michel Huerre, Elisabeth Carniel & Christian E. Demeure. (2012) An Encapsulated Yersinia pseudotuberculosis Is a Highly Efficient Vaccine against Pneumonic Plague. PLoS Neglected Tropical Diseases 6:2, pages e1528.
Crossref
Mary Kate Hart, George A. Saviolakis, Susan L. Welkos & Robert V. House. (2012) Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges. Advances in Preventive Medicine 2012, pages 1-14.
Crossref
Yue Zhang, Patricio Mena, Galina Romanov, Jr-Shiuan Lin, Stephen T. Smiley & James B. Bliska. (2012) A Protective Epitope in Type III Effector YopE Is a Major CD8 T Cell Antigen during Primary Infection with Yersinia pseudotuberculosis. Infection and Immunity 80:1, pages 206-214.
Crossref
Vladimir P. Zav’yalov. 2012. Advances in Yersinia Research. Advances in Yersinia Research 183 201 .
Yinon Levy, Yehuda Flashner, Avital Tidhar, Ayelet Zauberman, Moshe Aftalion, Shirley Lazar, David Gur, Avigdor Shafferman & Emanuelle Mamroud. (2011) T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague. Vaccine 29:40, pages 6866-6873.
Crossref
Shixia Wang, Jon D. Goguen, Fusheng Li & Shan Lu. (2011) Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge. Vaccine 29:39, pages 6802-6809.
Crossref
Jr-Shiuan Lin, Frank M. Szaba, Lawrence W. Kummer, Brett A. Chromy & Stephen T. Smiley. (2011) Yersinia pestis YopE Contains a Dominant CD8 T Cell Epitope that Confers Protection in a Mouse Model of Pneumonic Plague . The Journal of Immunology 187:2, pages 897-904.
Crossref
A. A. Byvalov & Yu. S. Ovodov. (2011) Immunobiological properties of Yersinia pestis antigens. Russian Journal of Bioorganic Chemistry 37:4, pages 400-410.
Crossref
Jason A. Rosenzweig, Olufisayo Jejelowo, Jian Sha, Tatiana E. Erova, Sheri M. Brackman, Michelle L. Kirtley, Cristina J. van Lier & Ashok K. Chopra. (2011) Progress on plague vaccine development. Applied Microbiology and Biotechnology 91:2, pages 265-286.
Crossref
Oretta Finco, Elisabetta Frigimelica, Francesca Buricchi, Roberto Petracca, Giuliano Galli, Elisa Faenzi, Eva Meoni, Alessandra Bonci, Mauro Agnusdei, Filomena Nardelli, Erika Bartolini, Maria Scarselli, Elena Caproni, Donatello Laera, Luisanna Zedda, David Skibinski, Serena Giovinazzi, Riccardo Bastone, Elvira Ianni, Roberto Cevenini, Guido Grandi & Renata Grifantini. (2011) Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines . Proceedings of the National Academy of Sciences 108:24, pages 9969-9974.
Crossref
Martin E. Schriefer & Jeannine M. Petersen. 2011. Manual of Clinical Microbiology. Manual of Clinical Microbiology 627 638 .
Wei Sun, David Six, Xiaoying Kuang, Kenneth L. Roland, Christian R.H. Raetz & Roy CurtissIIIIII. (2011) A live attenuated strain of Yersinia pestis KIM as a vaccine against plague. Vaccine 29:16, pages 2986-2998.
Crossref
Lauriane E. Quenee, Nancy Ciletti, Bryan Berube, Thomas Krausz, Derek Elli, Timothy Hermanas & Olaf Schneewind. (2011) Plague in Guinea Pigs and Its Prevention by Subunit Vaccines. The American Journal of Pathology 178:4, pages 1689-1700.
Crossref
Jr-Shiuan Lin, Lawrence W. Kummer, Frank M. Szaba & Stephen T. Smiley. (2011) IL-17 Contributes to Cell-Mediated Defense against Pulmonary Yersinia pestis Infection . The Journal of Immunology 186:3, pages 1675-1684.
Crossref
R. Colby Layton, Trevor Brasel, Andrew Gigliotti, Edward Barr, Steven Storch, Leslie Myers, Charles Hobbs & Frederick Koster. (2010) Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation. Journal of Medical Primatology 40:1, pages 6-17.
Crossref
David A. Hokey & Amit Misra. (2011) Aerosol vaccines for tuberculosis: A fine line between protection and pathology. Tuberculosis 91:1, pages 82-85.
Crossref
Jr-Shiuan Lin, Steven Park, Jeffrey J. Adamovicz, Jim Hill, James B. Bliska, Christopher K. Cote, David S. Perlin, Kei Amemiya & Stephen T. Smiley. (2010) TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Vaccine 29:2, pages 357-362.
Crossref
Benoît Quintard, Thierry Petit, Nathalie Ruvoen, Elisabeth Carniel & Christian E. Demeure. (2010) Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis. Comparative Immunology, Microbiology and Infectious Diseases 33:6, pages e59-e65.
Crossref
Y. Qiu, Y. Liu, Z. Qi, W. Wang, Z. Kou, Q. Zhang, G. Liu, T. Liu, Y. Yang, X. Yang, Y. Xin, C. Li, B. Cui, S. Huang, H. Liu, L. Zeng, Z. Wang, R. Yang, H. Wang & X. Wang. (2010) Comparison of Immunological Responses of Plague Vaccines F1 + rV270 and EV76 in Chinese-Origin Rhesus Macaque, Macaca mulatta. Scandinavian Journal of Immunology 72:5, pages 425-433.
Crossref
Patricia Fellows, Jeffrey Adamovicz, Justin Hartings, Robert Sherwood, William Mega, Trevor Brasel, Ed Barr, Lou Holland, Winston Lin, Amanda Rom, William Blackwelder, Jessica Price, Stephen Morris, Doris Snow & Mary Kate Hart. (2010) Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V). Vaccine 28:49, pages 7748-7756.
Crossref
Juliette K. Tinker, Chadwick T. Davis & Britni M. Arlian. (2010) Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV–cholera toxin A2/B chimeras. Protein Expression and Purification 74:1, pages 16-23.
Crossref
Bo Wang, Zhao Lan Mo, Peng Xiao, Jie Li, Yu Xia Zou, Bin Hao & Gui Yang Li. (2010) EseD, a Putative T3SS Translocon Component of Edwardsiella tarda, Contributes to Virulence in Fish and is a Candidate for Vaccine Development. Marine Biotechnology 12:6, pages 678-685.
Crossref
Dennis W. Metzger. (2010) Interleukin-12 as an adjuvant for induction of protective antibody responses. Cytokine 52:1-2, pages 102-107.
Crossref
Yoonkyung Do, Hyein Koh, Chae Gyu Park, Diana Dudziak, Patrick Seo, S. Mehandru, Jae-Hoon Choi, Cheolho Cheong, Steven Park, David S. Perlin, Bradford S. Powell & Ralph M. Steinman. (2010) Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague. European Journal of Immunology 40:10, pages 2791-2796.
Crossref
A. A. Byvalov & V. V. Kutyrev. (2010) The Experience of Application of <i>Yersinia pestis</i> Antigens for Plague Chemical Vaccine Development. Problems of Particularly Dangerous Infections:4(106), pages 47-50.
Crossref
Estela M. Galván, Manoj Kumar Mohan Nair, Huaiqing Chen, Fabio Del Piero & Dieter M. Schifferli. (2010) Biosafety Level 2 Model of Pneumonic Plague and Protection Studies with F1 and Psa. Infection and Immunity 78:8, pages 3443-3453.
Crossref
Joseph N. Brewoo, Tim D. Powell, Dan T. Stinchcomb & Jorge E. Osorio. (2010) Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice. Vaccine 28:36, pages 5891-5899.
Crossref
Julie L. BoyerCarolina Sofer-PodestaJohn AngNeil R. HackettMaria J. ChiuchioloSvetlana SeninaDavid PerlinRonald G. Crystal. (2010) Protective Immunity Against a Lethal Respiratory Yersinia pestis Challenge Induced by V Antigen or the F1 Capsular Antigen Incorporated into Adenovirus Capsid . Human Gene Therapy 21:7, pages 891-901.
Crossref
Sergio Rosales-Mendoza, Ruth E. Soria-Guerra, Leticia Moreno-Fierros, Ángel G. Alpuche-Solís, Luzmila Martínez-González & Schuyler S. Korban. (2010) Expression of an immunogenic F1-V fusion protein in lettuce as a plant-based vaccine against plague. Planta 232:2, pages 409-416.
Crossref
Yue Zhang & James B. Bliska. (2010) YopJ-Promoted Cytotoxicity and Systemic Colonization Are Associated with High Levels of Murine Interleukin-18, Gamma Interferon, and Neutrophils in a Live Vaccine Model of Yersinia pseudotuberculosis Infection . Infection and Immunity 78:5, pages 2329-2341.
Crossref
Vladimir Zav'yalov, Anton Zavialov, Galina Zav'yalova & Timo Korpela. (2010) Adhesive organelles of Gram-negative pathogens assembled with the classical chaperone/usher machinery: structure and function from a clinical standpoint. FEMS Microbiology Reviews 34:3, pages 317-378.
Crossref
Wei Sun, Kenneth L. Roland, Xiaoying Kuang, Christine G. Branger & Roy CurtissIIIIII. (2010) Yersinia pestis with Regulated Delayed Attenuation as a Vaccine Candidate To Induce Protective Immunity against Plague . Infection and Immunity 78:3, pages 1304-1313.
Crossref
Nihal A. Okan, Patricio Mena, Jorge L. Benach, James B. Bliska & A. Wali Karzai. (2010) The smpB-ssrA Mutant of Yersinia pestis Functions as a Live Attenuated Vaccine To Protect Mice against Pulmonary Plague Infection . Infection and Immunity 78:3, pages 1284-1293.
Crossref
K Ramirez, Y Ditamo, L Rodriguez, W L Picking, M L van Roosmalen, K Leenhouts & M F Pasetti. (2010) Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection. Mucosal Immunology 3:2, pages 159-171.
Crossref
P. Calderón, J.J. Castón, A. Rivero & J. Torre-Cisneros. (2010) Infecciones por Yersinia. Medicine - Programa de Formación Médica Continuada Acreditado 10:52, pages 3502-3508.
Crossref
Lauriane E. Quenee, Bryan J. Berube, Joshua Segal, Derek Elli, Nancy A. Ciletti, Deborah Anderson & Olaf Schneewind. (2010) Amino acid residues 196–225 of LcrV represent a plague protective epitope. Vaccine 28:7, pages 1870-1876.
Crossref
Zhizhen Qi, Lei Zhou, Qingwen Zhang, Lingling Ren, Ruixia Dai, Benchuan Wu, Tang Wang, Ziwen Zhu, Yonghai Yang, Baizhong Cui, Zuyun Wang, Hu Wang, Yefeng Qiu, Zhaobiao Guo, Ruifu Yang & Xiaoyi Wang. (2010) Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. Vaccine 28:6, pages 1655-1660.
Crossref
M. Lucrecia Alvarez & Guy A. Cardineau. (2010) Prevention of bubonic and pneumonic plague using plant-derived vaccines. Biotechnology Advances 28:1, pages 184-196.
Crossref
James B. Bliska. 2010. The Challenge of Highly Pathogenic Microorganisms. The Challenge of Highly Pathogenic Microorganisms 31 44 .
B. Joseph Hinnebusch. 2010. National Institute of Allergy and Infectious Diseases, NIH. National Institute of Allergy and Infectious Diseases, NIH 87 94 .
Frank M. Szaba, Lawrence W. Kummer, Lindsey B. Wilhelm, Jr-Shiuan Lin, Michelle A. Parent, Sara W. Montminy-Paquette, Egil Lien, Lawrence L. Johnson & Stephen T. Smiley. (2009) D27-pLpxL, an Avirulent Strain of Yersinia pestis , Primes T Cells That Protect against Pneumonic Plague . Infection and Immunity 77:10, pages 4295-4304.
Crossref
Bei Li, Lei Zhou, JingYu Guo, Xiaoyi Wang, Bin Ni, Yuehua Ke, Ziwen Zhu, Zhaobiao Guo & Ruifu Yang. (2009) High-Throughput Identification of New Protective Antigens from a Yersinia pestis Live Vaccine by Enzyme-Linked Immunospot Assay . Infection and Immunity 77:10, pages 4356-4361.
Crossref
Betty L. Noel, Sarit Lilo, Daniel Capurso, Jim Hill & James B. Bliska. (2009) Yersinia pestis Can Bypass Protective Antibodies to LcrV and Activation with Gamma Interferon To Survive and Induce Apoptosis in Murine Macrophages . Clinical and Vaccine Immunology 16:10, pages 1457-1466.
Crossref
Wei Sun, Kenneth L. Roland, Christine G. Branger, Xiaoying Kuang & Roy Curtiss. (2009) The Role of relA and spoT in Yersinia pestis KIM5+ Pathogenicity. PLoS ONE 4:8, pages e6720.
Crossref
Claire A. Cornelius, Lauriane E. Quenee, Derek Elli, Nancy A. Ciletti & Olaf Schneewind. (2009) Yersinia pestis IS 1541 Transposition Provides for Escape from Plague Immunity . Infection and Immunity 77:5, pages 1807-1816.
Crossref
Karina Ramirez, Alejandra V. E. Capozzo, Scott A. Lloyd, Marcelo B. Sztein, James P. Nataro & Marcela F. Pasetti. (2009) Mucosally Delivered Salmonella Typhi Expressing the Yersinia pestis F1 Antigen Elicits Mucosal and Systemic Immunity Early in Life and Primes the Neonatal Immune System for a Vigorous Anamnestic Response to Parenteral F1 Boost . The Journal of Immunology 182:2, pages 1211-1222.
Crossref
Grant W. WATERER & Hannah ROBERTSON. (2009) Bioterrorism for the respiratory physician. Respirology 14:1, pages 5-11.
Crossref
Claire A. Cornelius, Lauriane E. Quenee, Katie A. Overheim, Frederick Koster, Trevor L. Brasel, Derek Elli, Nancy A. Ciletti & Olaf Schneewind. (2008) Immunization with Recombinant V10 Protects Cynomolgus Macaques from Lethal Pneumonic Plague. Infection and Immunity 76:12, pages 5588-5597.
Crossref
Lawrence W. Kummer, Frank M. Szaba, Michelle A. Parent, Jeffrey J. Adamovicz, Jim Hill, Lawrence L. Johnson & Stephen T. Smiley. (2008) Antibodies and cytokines independently protect against pneumonic plague. Vaccine 26:52, pages 6901-6907.
Crossref
Maya I. Ivanov, Betty L. Noel, Ryan Rampersaud, Patricio Mena, Jorge L. Benach & James B. Bliska. (2008) Vaccination of Mice with a Yop Translocon Complex Elicits Antibodies That Are Protective against Infection with F1 − Yersinia pestis . Infection and Immunity 76:11, pages 5181-5190.
Crossref
Anasuya Chattopadhyay, Steven Park, Guillaume Delmas, Rema Suresh, Svetlana Senina, David S. Perlin & John K. Rose. (2008) Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection. Vaccine 26:50, pages 6329-6337.
Crossref
Brice Barefoot, Natalie J. Thornburg, Daniel H. Barouch, Jae-sung Yu, Christopher Sample, Robert E. Johnston, Hua Xin Liao, Thomas B. Kepler, Barton F. Haynes & Elizabeth Ramsburg. (2008) Comparison of multiple vaccine vectors in a single heterologous prime-boost trial. Vaccine 26:48, pages 6108-6118.
Crossref
Richard T. Robinson, Shabaana A. Khader, Richard M. Locksley, Egil Lien, Stephen T. Smiley & Andrea M. Cooper. (2008) Yersinia pestis Evades TLR4-dependent Induction of IL-12(p40)2 by Dendritic Cells and Subsequent Cell Migration . The Journal of Immunology 181:8, pages 5560-5567.
Crossref
Christina L. Airhart, Harold N. Rohde, Carolyn J. Hovde, Gregory A. Bohach, Claudia F. Deobald, Stephen S. Lee & Scott A. Minnich. (2008) Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine. Vaccine 26:44, pages 5554-5561.
Crossref
Thierry Blisnick, Patrick Ave, Michel Huerre, Elisabeth Carniel & Christian E. Demeure. (2008) Oral Vaccination against Bubonic Plague Using a Live Avirulent Yersinia pseudotuberculosis Strain . Infection and Immunity 76:8, pages 3808-3816.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.